5.01 0.03 (0.60%)

68.63% Fall from 52W High

963.7K XNAS Volume

High volume today

XNAS 19 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Precision Biosciences Inc is on 27 Mar 2025 for the purpose of Precision BioSciences Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Precision Biosciences Inc

The latest disclosure was made by John Alexander Kelly in Precision Biosciences Inc where a trade of 1,702 Restricted Stock Units done was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 1,702 0 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 1,702 86,256 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 4.91 per share. 03 Mar 2025 272 25,000 (0%) 0% 4.9 1,336 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 919 25,272 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 919 0 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 519 0 - - Restricted Stock Units
Jeff Smith Chief Research Officer Sale of securities on an exchange or to another person at price $ 4.91 per share. 03 Mar 2025 154 87,805 (0%) 0% 4.9 756 Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 519 87,959 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 26,575 53,150 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 44,368 84,554 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 3,889 3,888 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 13,904 27,801 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 4.79 per share. 20 Jan 2025 8,928 24,353 (0%) 0% 4.8 42,765 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 25,312 33,281 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 14,908 29,815 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 8,427 16,850 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 1,977 1,978 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 69,421 138,842 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 115,388 143,925 (0%) 0% - Common Stock
Michael Amoroso Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.67 per share. 20 Jan 2025 36,838 107,087 (0%) 0% 4.7 172,033 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 8,888 8,888 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 37,079 74,138 - - Restricted Stock Units
Jeff Smith Chief Research Officer Sale of securities on an exchange or to another person at price $ 4.79 per share. 20 Jan 2025 10,287 87,440 (0%) 0% 4.8 49,275 Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 29,168 97,727 (0%) 0% - Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 16,219 32,438 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 10,449 20,894 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2025 2,500 2,500 - - Restricted Stock Units
Geno J. Germano Director Purchase of securities on an exchange or from another person at price $ 4.49 per share. 30 Dec 2024 3,605 7,807 (0%) 0% 4.5 16,186 Common Stock
John Kelly Alexander Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.75 per share. 27 Dec 2024 2,113 40,186 (0%) 0% 4.8 10,037 Common Stock
J. Kevin Buehler Director Purchase of securities on an exchange or from another person at price $ 4.88 per share. 27 Dec 2024 4,320 8,712 (0%) 0% 4.9 21,082 Common Stock
Melinda Brown Director Purchase of securities on an exchange or from another person at price $ 4.55 per share. 26 Dec 2024 3,016 7,218 (0%) 0% 4.6 13,723 Common Stock
John Alexander Kelly Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 6.76 per share. 21 Nov 2024 3,000 38,073 (0%) 0% 6.8 20,280 Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2024 3,605 3,605 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2024 3,605 35,073 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2024 1,836 8,557 (0%) 0% 0 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2024 1,836 1,835 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 8.19 per share. 02 Nov 2024 588 7,969 (0%) 0% 8.2 4,816 Common Stock
Michael Amoroso Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.19 per share. 02 Nov 2024 3,012 28,537 (0%) 0% 8.2 24,668 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2024 9,443 9,444 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2024 9,443 31,549 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2024 79,725 79,725 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2024 44,723 44,723 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2024 208,263 208,263 - - Restricted Stock Units
Jeff Smith Chief Research Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2024 48,657 48,657 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 454 31,468 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 454 0 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 301 6,814 (0%) 0% 0 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 301 0 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 11.78 per share. 07 Jun 2024 93 6,721 (0%) 0% 11.8 1,096 Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 163 68,609 (0%) 0% - Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 163 0 - - Restricted Stock Units
Jeff Smith Chief Research Officer Sale of securities on an exchange or to another person at price $ 11.80 per share. 07 Jun 2024 50 68,559 (0%) 0% 11.8 590 Common Stock
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 9,826 9,826 - - Restricted Stock Units
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 9,826 9,826 - - Restricted Stock Units
Samuel C. Wadsworth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 9,826 9,826 - - Restricted Stock Units
Melinda Brown Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 9,826 9,826 - - Restricted Stock Units
Stanley R. Frankel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 9,826 9,826 - - Restricted Stock Units
Shari Lisa Pire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 9,826 9,826 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 12.00 per share. 08 May 2024 8,334 31,014 (0%) 0% 12 100,008 Common Stock
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 12.00 per share. 08 May 2024 833 6,513 (0%) 0% 12 9,996 Common Stock
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 12.00 per share. 08 May 2024 8,334 22,106 (0%) 0% 12 100,008 Common Stock
Jeff Smith Chief Research Officer Grant, award, or other acquisition of securities at price $ 12.00 per share. 08 May 2024 833 68,446 (0%) 0% 12 9,996 Common Stock
Geno J. Germano Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 4,202 (0%) 0% - Common Stock
Geno J. Germano Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 0 - - Restricted Stock Units
Kevin J. Buehler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 4,392 (0%) 0% - Common Stock
Kevin J. Buehler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 0 - - Restricted Stock Units
Samuel C. Wadsworth Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 4,202 (0%) 0% - Common Stock
Samuel C. Wadsworth Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 0 - - Restricted Stock Units
Melinda Brown Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 4,202 (0%) 0% - Common Stock
Melinda Brown Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 0 - - Restricted Stock Units
Stanley R. Frankel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 0 - - Restricted Stock Units
Stanley R. Frankel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 4,252 (0%) 0% - Common Stock
Shari Lisa Pire Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 4,202 (0%) 0% - Common Stock
Shari Lisa Pire Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 4,202 0 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 May 2024 918 919 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2024 918 5,952 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 10.32 per share. 01 May 2024 272 5,680 (0%) 0% 10.3 2,807 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2024 3,417 3,417 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Sale of securities on an exchange or to another person at price $ 10.32 per share. 01 May 2024 1,526 13,772 (0%) 0% 10.3 15,748 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2024 3,417 15,298 (0%) 0% - Common Stock
Alan List Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.32 per share. 01 May 2024 290 4,488 (0%) 0% 10.3 2,993 Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2024 982 981 - - Restricted Stock Units
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2024 982 4,778 (0%) 0% - Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2024 868 4,034 (0%) 0% - Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2024 868 0 - - Restricted Stock Units
Alan List Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.03 per share. 26 Apr 2024 238 3,796 (0%) 0% 10.0 2,386 Common Stock
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 41,705 41,705 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 25,277 25,277 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 111,217 111,217 - - Restricted Stock Units
Jeff Smith Chief Research Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 31,343 31,343 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 1,702 1,702 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 18.50 per share. 29 Feb 2024 506 20,978 (0%) 0% 18.5 9,361 Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 1,702 22,680 (0%) 0% - Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 519 519 - - Restricted Stock Units
Jeff Smith Chief Research Officer Grant, award, or other acquisition of securities at price $ 12.42 per share. 29 Feb 2024 1,006 67,248 (0%) 0% 12.4 12,495 Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 519 67,767 (0%) 0% - Common Stock
Jeff Smith Chief Research Officer Sale of securities on an exchange or to another person at price $ 10.32 per share. 29 Feb 2024 154 67,613 (0%) 0% 10.3 1,589 Common Stock
Scimeca Dario General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 0.36 per share. 20 Jan 2024 21,287 151,028 (0%) 0% 0.4 7,663 Common Stock
Smith Jeff Chief Research Officer Sale of securities on an exchange or to another person at price $ 0.37 per share. 20 Jan 2024 28,000 1,987,269 (3%) 0% 0.4 10,360 Common Stock
Amoroso Michael Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 266,720 493,823 (0%) 0% - Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 60,012 116,508 (0%) 0% - Common Stock
Michael Amoroso Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.36 per share. 20 Jan 2024 137,390 356,433 (0%) 0% 0.4 49,460 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 266,720 533,280 - - Restricted Stock Units
Kelly John Alexander Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 116,690 233,310 - - Restricted Stock Units
Scimeca Dario General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 59,345 118,655 - - Restricted Stock Units
Kelly John Alexander Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 116,690 614,169 (1%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 59,345 172,315 (0%) 0% - Common Stock
List Alan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 60,012 119,988 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 75,015 2,015,269 (3%) 0% - Common Stock
Alan List Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.36 per share. 20 Jan 2024 21,526 94,982 (0%) 0% 0.4 7,749 Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2024 75,015 149,985 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.48 per share. 18 Aug 2023 90,000 383,340 (0%) 0% 0.5 43,200 Common Stock
Shane Barton VP & Corporate Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 6,060 27,502 (0%) 0% - Common Stock
Shane Barton VP & Corporate Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 6,060 6,060 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 34,091 0 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 13,635 293,340 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 34,091 279,705 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 13,635 13,635 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 22,727 0 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 0.75 per share. 07 Jun 2023 13,361 68,473 (0%) 0% 0.8 10,021 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 9,044 81,834 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 22,727 72,790 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 9,044 9,045 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 4,872 4,872 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2023 4,872 1,935,079 (3%) 0% - Common Stock
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 126,075 126,075 - - Restricted Stock Units
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 126,075 126,075 - - Restricted Stock Units
Samuel C. Wadsworth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 126,075 126,075 - - Restricted Stock Units
Melinda Brown Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 126,075 126,075 - - Restricted Stock Units
Stanley R. Frankel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 126,075 126,075 - - Restricted Stock Units
Shari Lisa Pire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 126,075 126,075 - - Restricted Stock Units
Alan List Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.79 per share. 26 Apr 2023 7,771 56,496 (0%) 0% 0.8 6,139 Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 26,027 26,028 - - Restricted Stock Units
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 26,027 64,267 (0%) 0% - Common Stock
Kevin J. Buehler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Apr 2023 5,701 5,701 (0%) 0% - Common Stock
Kevin J. Buehler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Apr 2023 5,701 0 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.82 per share. 21 Mar 2023 46,999 68,738 (0%) 0% 0.8 38,539 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2023 102,535 115,737 (0%) 0% - Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2023 102,535 205,009 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.86 per share. 17 Mar 2023 20,000 245,614 (0%) 0% 0.9 17,200 Common Stock
Shane Barton VP & Corporate Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2023 12,722 25,439 - - Restricted Stock Units
Shane Barton VP & Corporate Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2023 12,722 21,422 (0%) 0% - Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2023 29,453 47,713 (0%) 0% - Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2023 29,453 58,890 - - Restricted Stock Units
Alan List Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.07 per share. 03 Mar 2023 9,473 38,240 (0%) 0% 1.1 10,136 Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 51,071 225,614 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 51,071 102,114 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.95 per share. 28 Feb 2023 11,605 174,543 (0%) 0% 1.0 11,025 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 27,558 62,235 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 27,558 55,101 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 1.07 per share. 28 Feb 2023 12,172 50,063 (0%) 0% 1.1 13,024 Common Stock
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.95 per share. 28 Feb 2023 2,163 34,677 (0%) 0% 1.0 2,055 Common Stock
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 15,576 31,144 - - Restricted Stock Units
Jeff Smith Chief Research Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 15,576 1,930,207 (3%) 0% - Common Stock
Jeff Smith Chief Research Officer Grant, award, or other acquisition of securities at price $ 0.95 per share. 28 Feb 2023 12,157 1,914,631 (3%) 0% 0.9 11,549 Common Stock
Shane Barton VP & Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 70,000 70,000 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 350,000 350,000 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 178,000 178,000 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 800,000 800,000 - - Restricted Stock Units
Alan List Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 180,000 180,000 - - Restricted Stock Units
Jeff Smith Chief Research Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 225,000 225,000 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2022 165,200 165,200 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2022 850,000 850,000 - - Restricted Stock Units
Alexander John Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2022 324,500 324,500 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2022 250,000 250,000 - - Stock Option (Right to Buy)
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 24,208 0 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.32 per share. 15 Oct 2022 11,006 13,202 (0%) 0% 1.3 14,528 Common Stock
Michael Amoroso Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 24,208 24,208 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.23 per share. 22 Sep 2022 8,200 162,938 (0%) 0% 1.2 10,086 Common Stock
John Alexander Kelly Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.34 per share. 22 Sep 2022 37,037 154,738 (0%) 0% 1.3 49,630 Common Stock
John Alexander Kelly Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.50 per share. 22 Jun 2022 33,784 117,701 (0%) 0% 1.5 50,676 Common Stock
Shane Barton VP & Corporate Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 6,061 8,720 (0%) 0% - Common Stock
Shane Barton VP & Corporate Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 6,061 12,120 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 13,638 83,917 (0%) 0% - Common Stock
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 13,638 27,270 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 34,090 34,091 - - Restricted Stock Units
John Alexander Kelly Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 34,090 70,279 (0%) 0% - Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 29,545 29,545 - - Restricted Stock Units
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 29,545 4,061,824 (7%) 0% - Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 12,199 4,074,023 (8%) 0% - Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 2.06 per share. 07 Jun 2022 18,849 4,055,174 (7%) 0% 2.1 38,829 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 12,199 24,391 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 9,047 42,347 (0%) 0% - Common Stock
Dario Scimeca General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 2.06 per share. 07 Jun 2022 9,833 32,514 (0%) 0% 2.1 20,256 Common Stock
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 22,727 22,727 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 9,047 18,089 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2022 22,727 33,300 (0%) 0% - Common Stock
Melinda Brown Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 376,683 376,683 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 156,951 156,951 - - Stock Option (Right to Buy)
Raymond F. Schinazi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 156,951 156,951 - - Stock Option (Right to Buy)
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 156,951 156,951 - - Stock Option (Right to Buy)
Samuel C. Wadsworth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 156,951 156,951 - - Stock Option (Right to Buy)
Shari Lisa Pire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 156,951 156,951 - - Stock Option (Right to Buy)
Stanley R. Frankel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 156,951 156,951 - - Stock Option (Right to Buy)
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2022 26,035 26,035 (0%) 0% - Common Stock
Alan List Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2022 26,035 52,055 - - Restricted Stock Units
Alan List Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.10 per share. 26 Apr 2022 7,775 18,260 (0%) 0% 2.1 16,328 Common Stock
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2022 5,701 5,701 - - Restricted Stock Units
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2022 8,763 8,763 - - Stock Option (Right to Buy)
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 307,544 307,544 - - Restricted Stock Units
Michael Amoroso Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 482,771 482,771 - - Employee Stock Option (Right to Buy)
John Alexander Kelly Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.08 per share. 17 Mar 2022 16,677 36,189 (0%) 0% 3.1 51,365 Common Stock
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 98,401 98,401 - - Restricted Stock Units
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 156,271 156,271 - - Employee Stock Option (Right to Buy)
Alan List Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 140,299 140,299 - - Employee Stock Option (Right to Buy)
Alan List Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 88,343 88,343 - - Restricted Stock Units
Samuel C. Wadsworth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 55,360 55,360 - - Stock Option (Right to Buy)
Shari Lisa Pire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 55,360 55,360 - - Stock Option (Right to Buy)
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2021 30,000 19,255 - - Employee Stock Option (Right to Buy)
David Thomson Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.65 per share. 23 Jun 2021 30,000 111,513 (0%) 0% 10.7 319,500 Common Stock
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 23 Jun 2021 30,000 141,513 (0%) 0% 1.2 35,400 Common Stock
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 21 Jun 2021 15,000 126,513 (0%) 0% 1.2 17,700 Common Stock
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jun 2021 15,000 49,255 - - Employee Stock Option (Right to Buy)
David Thomson Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.77 per share. 21 Jun 2021 15,000 111,513 (0%) 0% 10.8 161,550 Common Stock
David Thomson Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.44 per share. 17 Jun 2021 10,000 111,513 (0%) 0% 10.4 104,400 Common Stock
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jun 2021 10,000 64,255 - - Employee Stock Option (Right to Buy)
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jun 2021 10,000 74,255 - - Employee Stock Option (Right to Buy)
David Thomson Chief Operating Officer Sale of securities on an exchange or to another person at price $ 11.00 per share. 17 Jun 2021 10,000 111,513 (0%) 0% 11 110,000 Common Stock
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 17 Jun 2021 10,000 121,513 (0%) 0% 1.2 11,800 Common Stock
David Thomson Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 17 Jun 2021 10,000 121,513 (0%) 0% 1.2 11,800 Common Stock
Shane Barton VP & Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 31,242 31,242 - - Employee Stock Option (Right to Buy)
Shane Barton VP & Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 18,181 18,181 - - Restricted Stock Units
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 36,590 36,590 - - Restricted Stock Units
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 59,090 59,090 - - Restricted Stock Units
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 101,537 101,537 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 62,875 62,875 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 1,312 1,312 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 763 763 - - Restricted Stock Units
Fayaz Khazi CEO of Elo Life Systems Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 23,999 23,999 - - Restricted Stock Units
Fayaz Khazi CEO of Elo Life Systems Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 41,240 41,240 - - Employee Stock Option (Right to Buy)
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 27,136 27,136 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 46,629 46,629 - - Employee Stock Option (Right to Buy)
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 45,454 45,454 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 78,106 78,106 - - Employee Stock Option (Right to Buy)
Alan List Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 78,090 78,090 - - Restricted Stock Units
Alan List Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 134,186 134,186 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 9.38 per share. 17 May 2021 20,000 4,032,279 (7%) 0% 9.4 187,600 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 14 May 2021 21,514 4,061,952 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2021 21,514 0 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 9.17 per share. 14 May 2021 9,673 4,052,279 (7%) 0% 9.2 88,701 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 13 May 2021 21,514 2,023,272 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2021 21,514 0 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.96 per share. 13 May 2021 9,675 2,013,597 (3%) 0% 9.0 86,688 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 12 May 2021 21,514 4,050,111 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 12 May 2021 21,514 4,038,273 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.72 per share. 12 May 2021 9,676 4,028,597 (7%) 0% 8.7 84,375 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 May 2021 21,514 21,514 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 May 2021 21,514 43,028 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 9.15 per share. 12 May 2021 9,673 4,040,438 (7%) 0% 9.2 88,508 Common Stock
Shalini Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2021 32,800 32,800 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2021 32,800 32,800 - - Stock Option (Right to Buy)
Raymond F. Schinazi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2021 32,800 32,800 - - Stock Option (Right to Buy)
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2021 32,800 32,800 - - Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 07 May 2021 21,514 1,999,732 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2021 21,514 21,514 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2021 21,514 43,028 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.25 per share. 07 May 2021 9,746 2,001,758 (3%) 0% 8.3 80,405 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 07 May 2021 21,514 2,011,504 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.57 per share. 07 May 2021 9,742 1,989,990 (3%) 0% 8.6 83,489 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2021 13,422 0 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 21 Apr 2021 13,422 1,978,218 (3%) 0% 1.2 15,838 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.69 per share. 19 Apr 2021 9,676 4,016,759 (7%) 0% 8.7 84,084 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Apr 2021 21,514 64,542 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 19 Apr 2021 21,514 4,026,435 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.76 per share. 15 Apr 2021 9,676 3,993,082 (7%) 0% 8.8 84,762 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2021 21,514 86,056 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2021 21,514 107,570 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.84 per share. 15 Apr 2021 9,675 4,004,921 (7%) 0% 8.8 85,527 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 15 Apr 2021 21,514 4,014,596 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 15 Apr 2021 21,514 4,002,758 (7%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 12 Apr 2021 21,514 1,974,537 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.67 per share. 12 Apr 2021 9,741 1,964,796 (3%) 0% 8.7 84,454 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Apr 2021 21,514 64,542 - - Employee Stock Option (Right to Buy)
Stanley R. Frankel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2021 63,325 63,325 - - Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Apr 2021 21,514 107,570 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.87 per share. 08 Apr 2021 9,737 1,953,023 (3%) 0% 8.9 86,367 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 08 Apr 2021 21,514 1,962,760 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 08 Apr 2021 21,514 1,950,982 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.00 per share. 08 Apr 2021 9,736 1,941,246 (3%) 0% 9 87,624 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Apr 2021 21,514 86,056 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.08 per share. 18 Mar 2021 9,665 3,981,244 (7%) 0% 11.1 107,088 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2021 21,514 129,084 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 18 Mar 2021 21,514 3,990,909 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.97 per share. 16 Mar 2021 9,661 3,957,546 (7%) 0% 12.0 115,642 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 21,514 150,598 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 21,514 172,112 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.92 per share. 16 Mar 2021 9,665 3,969,395 (7%) 0% 10.9 105,542 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 16 Mar 2021 21,514 3,979,060 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 16 Mar 2021 21,514 3,967,207 (7%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 11.36 per share. 12 Mar 2021 9,712 1,929,468 (3%) 0% 11.4 110,328 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Mar 2021 21,514 129,084 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 12 Mar 2021 21,514 1,939,180 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 11.79 per share. 10 Mar 2021 9,710 1,905,863 (3%) 0% 11.8 114,481 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2021 21,514 150,598 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2021 21,514 172,112 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 11.38 per share. 10 Mar 2021 9,711 1,917,666 (3%) 0% 11.4 110,511 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 10 Mar 2021 21,514 1,927,377 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 10 Mar 2021 21,514 1,915,573 (3%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 12.04 per share. 22 Feb 2021 9,660 3,945,693 (7%) 0% 12.0 116,306 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Feb 2021 21,514 193,626 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 22 Feb 2021 21,514 3,955,353 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.55 per share. 18 Feb 2021 9,663 3,933,839 (7%) 0% 11.6 111,608 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2021 21,514 215,140 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2021 21,514 236,654 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 18 Feb 2021 21,514 3,943,502 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 12.20 per share. 18 Feb 2021 6,871 3,921,988 (7%) 0% 12.2 83,826 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 18 Feb 2021 21,514 3,928,859 (7%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.23 per share. 18 Feb 2021 9,705 1,889,446 (3%) 0% 12.2 118,692 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 18 Feb 2021 21,514 1,899,151 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2021 21,514 193,626 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.28 per share. 16 Feb 2021 9,705 1,877,637 (3%) 0% 12.3 119,177 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 16 Feb 2021 21,514 1,887,342 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 16 Feb 2021 21,514 1,875,525 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.30 per share. 16 Feb 2021 9,697 1,865,828 (3%) 0% 13.3 128,970 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2021 21,514 215,140 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2021 21,514 236,654 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 12.25 per share. 29 Jan 2021 6,444 3,907,345 (7%) 0% 12.3 78,939 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2021 21,515 258,168 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 29 Jan 2021 21,515 3,913,789 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.68 per share. 27 Jan 2021 7,048 3,877,204 (7%) 0% 11.7 82,321 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2021 21,514 279,683 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2021 21,514 301,197 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.97 per share. 27 Jan 2021 6,444 3,892,274 (7%) 0% 12.0 77,135 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 27 Jan 2021 21,514 3,898,718 (7%) 0% 0.0 861 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 27 Jan 2021 21,514 3,884,252 (7%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.37 per share. 26 Jan 2021 9,697 1,854,011 (3%) 0% 13.4 129,649 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2021 21,515 258,168 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 26 Jan 2021 21,515 1,863,708 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 22 Jan 2021 21,514 1,840,592 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jan 2021 21,514 279,683 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jan 2021 21,514 301,197 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.74 per share. 22 Jan 2021 9,695 1,842,193 (3%) 0% 13.7 133,209 Common Stock
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 22 Jan 2021 21,514 1,851,888 (3%) 0% 0.0 861 Common Stock
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.53 per share. 22 Jan 2021 10,218 1,830,374 (3%) 0% 13.5 138,250 Common Stock
David Thomson Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.49 per share. 21 Jan 2021 10,000 109,243 (0%) 0% 16.5 164,900 Common Stock
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2020 1,743 1,743 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2020 8,783 8,785 - - Employee Stock Options (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 15 Jun 2020 8,783 144,401 (0%) 0% 1.2 10,540 Common Stock
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 130,109 130,109 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 112,141 112,141 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 202,391 202,391 - - Employee Stock Option (Right to Buy)
Fayaz Khazi CEO of Elo Life Systems Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 107,391 107,391 - - Employee Stock Option (Right to Buy)
David Thomson Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 154,891 154,891 - - Employee Stock Option (Right to Buy)
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 108,424 108,424 - - Employee Stock Option (Right to Buy)
Christopher Heery Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 133,206 133,206 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 15 May 2020 8,783 134,740 (0%) 0% 1.2 10,540 Common Stock
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 15 May 2020 878 135,618 (0%) 0% 1.2 1,036 Common Stock
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2020 8,783 17,568 - - Employee Stock Options (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2020 878 3,514 - - Employee Stock Options (Right to Buy)
Shalini Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 41,038 41,038 - - Stock Option (Right to Buy)
Raymond F. Schinazi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 41,038 41,038 - - Stock Option (Right to Buy)
Kevin J. Buehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 41,038 41,038 - - Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 14 Apr 2020 4,392 3,862,738 (7%) 0% 1.2 5,183 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Apr 2020 4,392 5,854 - - Employee Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2020 71,776 71,776 - - Stock Option (Right To Buy)
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2020 82,659 82,659 - - Restricted Stock Units
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 4.61 per share. 28 Feb 2020 2,748 7,976 (0%) 0% 4.6 12,668 Common Stock
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 10.68 per share. 28 Feb 2020 548 8,524 (0%) 0% 10.7 5,853 Common Stock
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 3.61 per share. 28 Feb 2020 2,049 10,573 (0%) 0% 3.6 7,397 Common Stock
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2020 131,271 131,271 - - Employee Stock Option (Right to Buy)
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 5.61 per share. 28 Feb 2020 2,072 2,072 (0%) 0% 5.6 11,624 Common Stock
Dario Scimeca General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 4.79 per share. 28 Feb 2020 3,156 5,228 (0%) 0% 4.8 15,117 Common Stock
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2020 2,634 4,392 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2020 17,566 26,351 - - Employee Stock Options (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 06 Jan 2020 2,634 123,845 (0%) 0% 1.2 3,108 Common Stock
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 06 Jan 2020 17,566 121,211 (0%) 0% 1.2 21,079 Common Stock
Christopher Heery Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 12.09 per share. 19 Dec 2019 250 250 (0%) 0% 12.1 3,023 Common Stock
Christopher Heery Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 12.08 per share. 19 Dec 2019 2,235 2,485 (0%) 0% 12.1 26,999 Common Stock
Kevin J. Buehler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2019 60,776 60,776 - - Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2019 52,651 52,651 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2019 52,818 52,818 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2019 262,252 262,252 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Sep 2019 10,000 13,422 - - Employee Stock Option (Right to Buy)
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 23 Sep 2019 10,000 1,812,427 (3%) 0% 1.2 11,800 Common Stock
Fayaz Khazi CEO of Elo Life Systems Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2019 28,833 28,833 - - Employee Stock Option (Right to Buy)
David Thomson Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2019 30,922 30,922 - - Employee Stock Option (Right to Buy)
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 10 Sep 2019 13,176 3,858,346 (7%) 0% 1.2 15,548 Common Stock
Derek Jantz Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2019 13,176 10,246 - - Employee Stock Option (Right to Buy)
Dario Scimeca General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jul 2019 160,000 160,000 - - Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 10 Jun 2019 96,618 96,618 (0%) 0% 1.2 115,942 Common Stock
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2019 7,027 7,026 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2019 96,618 43,917 - - Employee Stock Option (Right to Buy)
Abid Ansari Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 10 Jun 2019 7,027 103,645 (0%) 0% 1.2 8,292 Common Stock
David Thomson Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2019 117,113 117,113 - - Employee Stock Option (Right to Buy)
David Thomson Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 10 Jun 2019 117,113 117,113 (0%) 0% 1.2 138,193 Common Stock
Tony Yao None Purchase of securities on an exchange or from another person at price $ 15.42 per share. 03 Apr 2019 6,487 158,003 (0%) 0% 15.4 100,030 Common Stock
Raymond F. Schinazi None 01 Apr 2019 36,946 36,946 (0%) 0% 13.6 502,466 Common Stock
Raymond F. Schinazi None 01 Apr 2019 56,102 93,048 (0%) 0% - Common Stock
Raymond F. Schinazi None 01 Apr 2019 119,761 0 - - Series B Preferred Stock
Tony Yao None 01 Apr 2019 244,572 0 - - Series B Preferred Stock
Tony Yao None 01 Apr 2019 9,500 0 - - Series B Preferred Stock
Tony Yao None 01 Apr 2019 9,500 0 - - Series B Preferred Stock
Tony Yao None 01 Apr 2019 4,450 4,450 (0%) 0% - Common Stock
Tony Yao None 01 Apr 2019 114,570 151,516 (0%) 0% - Common Stock
Tony Yao None 01 Apr 2019 36,946 36,946 (0%) 0% 13.6 502,466 Common Stock
Tony Yao None 01 Apr 2019 4,450 4,450 (0%) 0% - Common Stock
Raymond F. Schinazi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2019 34,544 34,544 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures